Angus Russell, chief executive of the speciality pharmaceutical firm Shire, has taken advantage of a strong performance from the group recently to sell a big chunk of shares.
He offloaded 17,219 at 1,029p each, or a total of about £177,000.
Following the sale Russell now has 96,331 shares in the group as well as various options and other rights.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Shares in Shire have rallied strongly in the past couple of months.
The company received a boost on Tuesday when it said data from the final two Phase III trials for its Gaucher disease treatment velaglucerase alfa met expectations.
Top Director Buys
Top Director Sells
Should your business invest in a VoIP phone service?
Here's what you need to know about VOIP (voice over IP) services before landlines go digital in 2025.
By David Prosser Published
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published